Interestingly, we observed that the survival time of glioma was inversely and significantly correlated (hazard ratio <1) with KCNMA1 expression level in all three validation datasets (Table 5), which is consistent with the finding from the UHC cohort. This evidence concerns the gene KCNMA1 and central nervous system cancer.